Skin cancer in immunosuppressed patients
Maize, J.C.
JAMA 237(17): 1857-1858
1977
ISSN/ISBN: 0098-7484 PMID: 321821 Document Number: 118320
Document emailed within 1 workday
Related Documents
Maize, J.C. 1977: Skin cancer in immunosuppressed patients JAMA 237(17): 1857-1858Rapini, R.P. 1988: Practical evaluation of skin lesions in immunosuppressed patients Cutis 42(2): 125-128
Bergfelt, L.; Larkö, O.; Blohmé, I. 1993: Skin disease in immunosuppressed patients in relation to epidermal Langerhans' cells Acta Dermato-Venereologica 73(5): 330-334
Penn, I. 1984: Cancer in immunosuppressed patients Transplantation Proceedings 16(2): 492-494
Holtzclaw, B.J.; Rutledge, D.N. 1990: Use of amphotericin B in immunosuppressed patients with cancer. Part Two: Pharmacodynamics and nursing implications Oncology Nursing Forum 17(5): 737-742
Guenoun, F.Z.; Doukan, S.; Bouree, P.; Vieillefond, A. 1990: A diffuse and persistent skin eruption in an immunosuppressed patient Annales de Pathologie 10(5-6): 365-366
Okazaki, H.; Maki, T.; Wood, M.L.; Monaco, A.P. 1981: Effect of blood transfusion on skin allograft survival in immunosuppressed mice Transplantation Proceedings 13(1 Part 1): 515-517
Mørk, N.J.; Braathen, L.R.; Rajka, G.; Hoel, P.S. 1988: Photochemotherapy and skin cancer. the occurrence of premalignant and malignant skin changes in patients with psoriasis treated with photochemotherapy (PUVA therapy) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 108(8-9): 676-678
Vogel, U.; Dybdahl, M.; Wallin, H.; Nexø, B.A. 2000: Treatment of psoriasis and skin cancer. Risk of skin cancer is affected by DNA repair capacity Ugeskrift for Laeger 162(50): 6861
Valtonen, V. 1979: Infections in immunosuppressed patients Duodecim; Laaketieteellinen Aikakauskirja 95(23): 1629-1638
Sadek Sabbour, M.; Abd-el-Hamid, T.; Hussein, S.K. 1984: Infection in immunosuppressed patients Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(1): 19-24
Ausina, V.; Matas, L.; Coll, P.; Sambeat, M.A.; Verger, G.; Prats, G. 1985: Nocardiosis in immunosuppressed patients Medicina Clinica 84(3): 90-95
Bouchaud, O. 1997: Vaccinations in immunosuppressed patients Annales de Medecine Interne 148(3): 272-279
Tosolini, F.A. 1979: Antibiotics in immunosuppressed patients Australian Family Physician 8(10): 1087-1097
Steinke, B.; Ostendorf, P.; Völker, H.e. 1981: Cytomegalic retinitis in immunosuppressed patients Die Medizinische Welt 32(44): 1658-1661
Sperl, J.; Franková, S.; Spicák, J. 2010: Viral hepatitis in immunosuppressed patients Klinicka Mikrobiologie a Infekcni Lekarstvi 16(4): 120-123
Moreb, J.; Morag, A.; Izsak, G.; Hershko, C. 1981: Interferon in immunosuppressed patients with disseminated herpes Harefuah 100(5): 209-210
Lau, G.K.K. 2005: Treatment of immunosuppressed chronic hepatitis B patients Medical Journal of Malaysia 60 Suppl B: 57-62
Terra, L.; Pellicanò, S. 1996: Norwegian scabies in immunosuppressed patients. Report of a case Minerva Medica 87(9): 423-425
Dreizen, S.; McCredie, K.B.; Bodey, G.P. 1979: Unusual mucocutaneous infections in immunosuppressed patients with leukemia Postgraduate Medicine 66(3): 131-4 137-41